[1]付芸芸,夏小军,秦大凯,等.扶金化积丸含药血清对肺癌A549细胞增殖及凋亡的影响[J].陕西中医,2025,46(4):440-444.[doi:DOI:10.3969/j.issn.1000-7369.2025.04.002]
　FU Yunyun,XIA Xiaojun,QIN Dakai,et al.Effect of Fujin Huaji pill containing serum on proliferation and apoptosis of lung cancer A549 cells[J].,2025,46(4):440-444.[doi:DOI:10.3969/j.issn.1000-7369.2025.04.002]
点击复制

扶金化积丸含药血清对肺癌A549细胞增殖及凋亡的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
46
期数:
2025年4期
页码:
440-444
栏目:
基础研究
出版日期:
2025-04-20

文章信息/Info

Title:
Effect of Fujin Huaji pill containing serum on proliferation and apoptosis of lung cancer A549 cells
作者:
付芸芸1; 夏小军2; 秦大凯1; 郭炳涛2; 付菲菲1; 任德祥1; 赵 峻1; 李 炜1; 李林洲1; 雷旭东2
(1.甘肃中医药大学,甘肃 兰州 730000; 2.甘肃省肿瘤医院,甘肃 兰州 730050)
Author(s):
FU Yunyun1; XIA Xiaojun2; QIN Dakai1; GUO Bingtao2; FU Feifei1; REN Dexiang1; ZHAO Jun1; LI Wei1; LI Linzhou1; LEI Xudong2
(1.Gansu University of Traditional Chinese Medicine,Lanzhou 730000,China; 2.Gansu Cancer Hospital,Lanzhou 730050,China)
关键词:
肺癌;  扶金化积丸;  细胞增殖;  凋亡;  细胞周期;  含药血清
Keywords:
Lung cancer;  Fujin Huaji pills;  Cell proliferation;  Apoptosis;  Cell cycle;  Drug serum
分类号:
R 734.2
DOI:
DOI:10.3969/j.issn.1000-7369.2025.04.002
文献标志码:
A
摘要:
目的:探讨扶金化积丸含药血清对肺癌A549细胞增殖及凋亡的影响及分子机制。方法:取SD大鼠40只,随机分为空白对照组和扶金化积丸组,空白对照组予等体积0.9%氯化钠溶液灌胃,给药组按生药量1.749 g/kg灌胃,提取并配制不同浓度含药血清(即150、75、37.5 mg/ml含药血清高、中、低剂量组)。A549细胞株复苏,取对数期细胞,以5×104/ml的密度接种至6孔培养板后继续培养至细胞贴壁,次日各实验组分别加入扶金化积丸高、中、低剂量含药血清500 μl/孔,待其干预细胞24 h后镜下观察细胞形态变化,拍照分析。MTT法检测含药血清对A549细胞的增殖抑制效应; 流式细胞术检测各组药物对细胞周期及凋亡的影响; Western blot法检测各组药物处理后凋亡蛋白Bax、Bcl-2的表达水平。结果:与空白对照组相比,扶金化积丸含药血清各剂量组均出现核固缩、圆细胞数量多且漂浮、胞质透亮且胞质内出现颗粒,细胞贴壁不牢,其中扶金化积丸含药血清高、中剂量组效果明显; 扶金化积丸高、中、低剂量组OD值较空白对照组明显减小(P<0.01或P<0.05); 扶金化积丸高、中剂量组G0/G1期A549细胞百分比显著增大,高剂量组S期、G2/M期A549细胞百分比明显减小(P<0.01或P<0.05); 扶金化积丸高、中、低剂量组A549细胞凋亡率均明显升高(P<0.01或P<0.05)。扶金化积丸高、中、低剂量组Bax表达及Bax/Bcl-2比例均上调(P<0.01),扶金化积丸高、中剂量组Bcl-2表达较空白对照组均下调(P<0.01或P<0.05)。结论:扶金化积丸含药血清能够抑制A549细胞的增殖,促进A549细胞凋亡,其机制可能与降低细胞中Bcl-2水平,增加Bax水平相关。
Abstract:
Objective:To investigate the effects of Fujin Huaji pill containing serum on the proliferation and apoptosis of lung cancer A549 cells and the possible molecular mechanism.Methods:A total of 40 SD rats were randomly divided into blank group and Fujin Huaji pill group.The blank group was given equal volume of normal saline by gavage,and the drug administration group was given gavage according to the drug dose of 1.749 g/kg.Serum containing different concentrations of SD was extracted and allocated to high,medium and low dose groups(150,75 and 37.5 mg/ml of SD serum).Cell line A549 was resuscitated,and the cells of log phase were inoculated into 6-well culture plates at a density of 5×104/ml,and then cultured until the cells stuck to the wall.The next day,each experimental group was added 500 μl/well of drug-containing serum in the high-dose,medium-dose and low-dose of Fujin Huaji pill,respectively.After 24 hours of intervention,the morphological changes of cells were observed under microscope and photographed for analysis.MTT assay was used to detect the proliferation inhibition effect of drug-containing serum on A549 cells.The effects of drugs on cell cycle and apoptosis were detected by flow cytometry.The expression levels of apoptotic proteins Bax and Bcl-2 were detected by Western blot.Results:Compared with the blank group,Fujin Huaji pill serum dose group showed nuclear pyretic,round cell number and floating,cytoplasm clear and granules in the cytoplasm,and cell adhesion was not firm,among which the effect of Fujin Huaji pill serum high and medium dose group was obvious.OD values in high,medium and low dose groups of Fujin Huaji pill were significantly decreased compared with blank control group(P<0.01 or P<0.05).The percentage of A549 cells in G0/G1stage was significantly increased in high and medium dose groups,and the percentage of A549 cells in S and G2/M stage was significantly decreased in high dose groups(P<0.01 or P<0.05).The apoptosis rate of A549 cells in high,medium and low dose groups of Fujin Huaji pill was significantly increased(P<0.01 or P<0.05).The expression of Bax and the proportion of Bax/Bcl-2 in serum high,medium and low dose groups of Fujin Huaji pill were up-regulated(P<0.01),and the expression of Bcl-2 in serum high and medium dose groups of Fujin Huaji pill was down-regulated compared with blank control group(P<0.01 or P<0.05).Conclusion:The serum containing Fujin Huaji pill can inhibit the proliferation of A549 cells and promote the apoptosis of A549 cells,which may be related to the decrease of Bcl-2 gene level and the increase of Bax gene level.

参考文献/References:

[1] RBERG C D,SCHILLER J H,BOFFETTA P,et al.Air pollution and lung cancer:A review by international association for the study of lung cancer early detection and screening committee[J].J Thorac Oncol,2023,18(10):1277-1289.
[2] CHENG T Y,CRAMB S M,BAADE P D,et al.The international epidemiology of lung cancer:Latest trends disparities,and tumor characteristics[J].J Thorac Oncol,2016,11(10):1653-1671.
[3] 王裕新,潘凯枫,李文庆.2022全球癌症统计报告解读[J].肿瘤综合治疗电子杂志,2024,10(3):1-16.
[4] BODOR J N,BOUMBER Y,BORGHAEI H.Biomarkers for immune checkpoint inhibitionin non-small cell lung cancer(NSCLC)[J].Cancer,2020,126(2):260-270.
[5] CHEN S,BAO Y,XU J,et al.Efficacy and safety of TCM combined with chemotherapy for SCLC:A systematic review and meta-analysis[J].J Cancer Res Clin Oncol,2020,146(11):2913-2935.
[6] 夏小军,雷旭东,段赟,等.扶金化积丸对Lewis肺癌荷瘤小鼠的抑瘤作用及机制[J].中成药,2022,44(1):67-71.
[7] 林德荣,梁艺钟,张斌.扶正抑瘤汤含药血清对胃癌SGC-7901细胞生长和凋亡的影响[J].四川中医,2019,37(10):62-66.
[8] 蒋义鑫,徐元,周之毅,等.金复康口服液诱导肺癌细胞A549凋亡的机制[J].中国实验方剂学杂志,2018,24(9):160-165.
[9] 牛俐燃,李冠聪,张婉婷,等.镰形棘豆黄酮含药血清对人肺癌A549细胞活力、凋亡及周期的影响[J].中药新药与临床药理,2019,30(7):790-795.
[10] 朱杨壮壮,张飞,焦肖宁,等.芦荟苦素对非小细胞肺癌A549细胞增殖及凋亡的影响[J].中国实验方剂学杂志,2019,25(14):13-18.
[11] 惠盼,谯钰琪,董济民,等.葡萄糖调节蛋白78表达与非小细胞肺癌临床病理特征相关性Meta分析[J].陕西医学杂志,2023,52(4):481-486,491.
[12] 王军徽,肖萌,马功贤,等.非小细胞肺癌中医药治疗研究进展[J].陕西中医,2023,44(11):1663-1665.
[13] 宁永波,王雅兴,陈香颖,等.名中医王瑞平“期证相合”理论在肺癌术后研究肿瘤微环境经验[J].陕西中医,2023,44(10):1448-1451.
[14] 马定财,王哲,王毛毛,等.黄芪及活性成分治疗肺癌的研究进展[J].中国中药杂志,2024,49(2):294-303.
[15] 魏征,张俊萍.化瘀解毒方含药血清对人肺癌A549细胞凋亡的作用及机制[J].中国老年学杂志,2023,43(1):163-166.
[16] 马玥,王立芳,郑展,等.肺岩宁方联合顺铂对肺癌A549细胞生物学行为的影响[J].中华中医药杂志,2022,37(6):3452-3456.
[17] ZANGOUEI A S,ZANGOUE M,TAGHEHCHIAN N,et al.Cell cycle related long non-coding RNAs as the critical regulators of breast cancer progression and metastasis[J].Biol Res,2023,56(1):1.
[18] OTTO T,SICINSKI P.Cell cycle proteins as promising targets in cancer therapy[J].Nat Rev Cancer,2017,17(2):93-115.
[19] 何邵波,罗甫花,蒋传命,等.红景天苷负向调控TACC2表达抑制NSCLC细胞增殖及上皮间充质转化[J].基础医学与临床,2022,42(11):1681.
[20] 刘艳霞,李雁.蠲瘤散结方对人肺腺癌A549细胞增殖和糖酵解的调控作用及机制研究[J].辽宁中医杂志,2024,51(8):1-10.
[21] DARCY M S.Cell death:A review of the major forms of apoptosis,necrosis and autophagy[J].Cell Biol Int,2019,43(6):582-592.
[22] LIU C,LIU Q,YAN A,et al.Metformin revent insulin-induced oxaliplatin resistance by activating mitochondrial apoptosis pathway in human colon cancer HCT116 cells[J].Cancer Med,2020,9(11):3875-3884.
[23] LAKHANI N J,RASCO D,WANG H,et al.First-in-human study with preclinical data of BCL-2/BCL-xL inhibitor pelcitoclax in locally advanced or metastatic solid tumors[J].Clin Cancer Res,2024,30(3):506-521.
[24] DADSENA S,KING L E,GARCIA-SAEZ A J.Apoptosis regulation at the mitochondria membrane level[J].Biochim Biophys Acta Biomembr,2021,1863(12):183716.
[25] LIU Y,ZUO H,WANG Y,et al.Ethanol promotes apoptosis in rat ovarian granulosa cells via the Bcl-2 family dependent intrinsic apoptotic pathway[J].Cell Mol Biol,2018,64(1):118-125.

相似文献/References:

[1]刘海涛 ,衣秀秀,田建辉△.肺癌中西医抗凝治疗研究进展*[J].陕西中医,2020,(1):127.
[2]邵翠丽,周晋华△,杨勤军,等.周晋华运用环磷酰胺联合中药紫杉治疗晚期肺癌经验*[J].陕西中医,2020,(2):223.
　SHAO Cuili,ZHOU Jinhua,YANG Qinjun,et al.ZHOU Jinhua treats advanced lung cancer with cyclophosphamide and purple shirt[J].,2020,(4):223.
[3]汪 莉,杜红旭,周正国,等.攻癌固真汤联合吉非替尼治疗肺癌气虚血瘀证疗效及对患者血流状态的影响[J].陕西中医,2021,(3):338.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.017]
　WANG Li,DU Hongxu,ZHOU Zhengguo,et al.Clinical effect of Gong'ai Guzhen decoction combined with gefitinib in treating lung cancer with Qixu Xueyu syndrome and affect blood flow state[J].,2021,(4):338.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.017]
[4]郑 茜,刘远婷,丁甜甜,等.消积抑癌方对Lewis肺癌荷瘤小鼠MMP-2的影响[J].陕西中医,2021,(7):844.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.007]
　ZHENG Qian,LIU Yuanting,DING Tiantian,et al.Effect of Xiaoji Yi'ai recipe on MMP-2 in Lewis lung cancer bearing mice[J].,2021,(4):844.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.007]
[5]刘文佳,刘宗凯,初晓苏,等.山慈菇-王不留行干预肺癌向骨转移过程生物信息学作用机制[J].陕西中医,2021,(9):1302.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.041]
[6]杨 昕,李和根.肺癌辨证分型研究进展[J].陕西中医,2021,(9):1313.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.043]
　YANG Xin,LI Hegen.Progress in syndrome differentiation of lung cancer[J].,2021,(4):1313.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.043]
[7]李 健,贾 瑞,王 超,等.健脾益气汤联合化疗对肺癌术后患者免疫功能的影响[J].陕西中医,2023,(4):459.[doi:DOI:10.3969/j.issn.1000-7369.2023.04.011]
　LI Jian,JIA Rui,WANG Chao,et al.Effect of Jianpi Yiqi decoction combined with chemotherapy on immune function in patients with lung cancer after surgery[J].,2023,(4):459.[doi:DOI:10.3969/j.issn.1000-7369.2023.04.011]
[8]宁永波,王雅兴,陈香颖,等.名中医王瑞平“期证相合”理论在肺癌术后研究肿瘤微环境经验[J].陕西中医,2023,(10):1448.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.026]
　NING Yongbo,WANG Yaxing,CHEN Xiangying,et al.Wang Ruiping's theory of “phase correspondence” in postoperative lung cancer patients[J].,2023,(4):1448.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.026]
[9]张 尤,陈 炜.名中医韩明向基于“一本四证”论治肺癌经验[J].陕西中医,2023,(12):1788.[doi:DOI:10.3969/j.issn.1000-7369.2023.12.027]
[10]陈香颖,宁永波,王雅兴,等.名中医王瑞平运用“培土生金法”治疗肺癌经验[J].陕西中医,2024,(4):536.[doi:DOI:10.3969/j.issn.1000-7369.2024.04.023]
　CHEN Xiangying,NING Yongbo,WANG Yaxing,et al.Experience of professor Wang Ruiping using “tonifying the spleen and replenishing the lung” to treat lung cancer[J].,2024,(4):536.[doi:DOI:10.3969/j.issn.1000-7369.2024.04.023]

备注/Memo

备注/Memo:
[基金项目]甘肃省自然科学基金资助项目(23JRRA1252); 甘肃省科技厅重点研发计划项目(24YFFA019); 甘肃省中医药人才培养重点学科建设项目[甘财社(2022)48号]; 甘肃省名中医传承工作室建设项目[国中医药规财函(2021)242]
更新日期/Last Update: 2025-04-08